Endoprosthetic replacement in patients with tumors of proximal humerus
Introduction Currently the organ-preserving surgical treatment (oncological arthroplasty) may be provided in 90% of patients with malignant lesions of the long bones and large joints. Due to the development and improvement of surgical techniques, the application of new antibacterial drugs, the devel...
Saved in:
| Main Authors: | V. Yu. Karpenko, V. A. Derzhavin, A. V. Buharov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2015-06-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/58 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological agents for endoprosthetic joint replacement in patients with rheumatoid arthritis
by: Viktoria Nikolaevna Khlaboshina, et al.
Published: (2014-12-01) -
PRIMARY ENDOPROSTHETIC REPLACEMENT OF THE ANOPHTHALMIC ORBIT IN PATIENTS WITH UVEAL MELANOMA: SIX-YEAR FOLLOW-UP RESULTS
by: A. A. Yarovoy, et al.
Published: (2015-04-01) -
Early rehabilitation of cancer patients after endoprosthetic reconstruction following resection of the lower extremity long bones
by: A. V. Bukharov, et al.
Published: (2022-11-01) -
SHOULD DISEASE-MODIFYING THERAPY BE STOPPED IN PATIENTS WITH RHEUMATOID ARTHRITIS BEFORE ENDOPROSTHETIC JOINT REPLACEMENT?
by: N. A. Savenkova, et al.
Published: (2011-06-01) -
Complications after endoprosthetic joint replacement in patients receiving genetically engineered biological agents
by: Elena Yuryevna Pogozheva, et al.
Published: (2012-06-01)